Citation data

OpenAlex

Works that cite this article, indexed by OpenAlex.

28 resultsUpdated October 24, 2026
2

Design, synthesis, and multi-target biological evaluation of 1,2,3-triazole linked indole–thiazolidinedione hybrids as potent α-glucosidase, α-amylase, and DPP-4 inhibitors with antioxidant potential

Journal of Molecular Structure 1349 (2025)

Anchal Sharma; Rupali Rana; Simranjot Kaur; Nitish Kumar; Karanvir Singh; Anmol Narang; Harmandeep Kaur Gulati; Jyoti Jyoti; Aanchal Khanna; Kavita Bhagat; Jatinder Vir Singh; Sukhraj Kaur; Chandni Sharma; Preet Mohinder Singh Bedi

3

Unveiling the research directions for pyrrolidine-based small molecules as versatile antidiabetic and anticancer agents

Future Medicinal Chemistry 17(9) (2025)

Shiv Kumar; Rupali Kohal; Debarshi Mondal; Shreya Kumari; Preety Kumari; Priya Bisht; Ghanshyam Das Gupta; Sant Kumar Verma

4

Inhibitors of Proteases: A Well-Grounded Strategy in Drug Development

Molecules 30(14) (2025)

Santo Previti; Roberta Ettari

5

Omarigliptin ameliorates cisplatin-induced renal damage: Cross-talk between glucagon-like peptide-1, HMGB1/RAGE/TLR4 signaling, and TXNIP/NLRP3 inflammasome/gasdermin D axis

Life Sciences 376 (2025)

Shuruq E. Alsufyani; Hany H. Arab; Azza A. K. El‐Sheikh; El‐Shaimaa A. Arafa; Ahmed Fouad Hussein Hashad; Reham M. Goda; Tamer Mohamed Naguib; Maaly A. Abd Elmaaboud; Mennatallah A. Elkady; Ahmed M. Kabel

6

Exploring the pharmacological versatility of triazolopyrazine: A multi-target scaffold for drug development

Future Medicinal Chemistry 17(23) (2025)

Debarshi Mondal; Priya Bisht; Preety Kumari; Shiv Kumar; Ghanshyam Das Gupta; Sant Kumar Verma

7

Brown adipose tissue: a potential therapeutic target for preventing cardiovascular disease in metabolic disorders

Diabetology & Metabolic Syndrome 17(1) (2025)

Tamara Egan Beňová; Matúš Sýkora; Katarína Ondreják Andelová; Veronika Farkašová; Marek Lepáček; Marta Šoltésová Prnová; Pavel Babál; Dávid Janko; Natália Andelová; Miroslav Ferko; Barbara Szeiffová Bačová

8

Design, Synthesis and Antidiabetic Activity of Novel Pyrrole‐3‐Carboximidamide Derivatives as Dipeptidyl Peptidase‐4 Inhibitors

Archiv der Pharmazie 358(8) (2025)

Hossein Fasihi Dastjerdi; Nima Naderi; Amir Garmabdari; Manijeh Nematpour; Melika Ebrahimi; Samaneh Hosseinpoor; Fatemeh Saberinasab; Zahra Sheikholislam; Omid Hosseini; Elham Rezaee; Sayyed Abbas Tabatabai

9

Unraveling the Antihyperglycemic Effects of Dipeptyl Peptidase-4 Inhibitors in Rodents: A Multi-Faceted Approach Combining Effects on Glucose Homeostasis, Molecular Docking, and ADMET Profiling

Pharmaceuticals 18(10) (2025)

Raquel Nascimento da Silva Roriz; Claudia Johana Pérez Cardozo; Gabriela Araújo Freire; Caio B. R. Martins; Raimundo Rigoberto Barbosa Xavier Filho; Leon Pereira; Gisele de Fátima Pinheiro Rangel; Tiago Lima Sampaio; Lyanna Rodrigues Ribeiro; Gisele Silvestre da Silva; Isabelle de Fátima Vieira Camelo Maia; Deysi Viviana Tenazoa Wong; Daniele O. B. Sousa; Ariclécio Cunha de Oliveira; Eduardo Reina; Lı́dia Moreira Lima; Walter José PELÁEZ; Matheus Nunes da Rocha; Márcia Machado Marinho; Hélcio Silva dos Santos; Emmanuel Silva Marinho; Jane Eire Silva Alencar de Menezes; Fátima Regina Mena Barreto Silva; Kirley Marques Canuto; Nylane Maria Nunes de Alencar; Marisa Jádna Silva Frederico

10

Unveiling the conformational analysis of N/S-methylene-N/S linked symmetrical scaffolds of 1,2-pyridazinone and 1,2,4-triazinone derivatives: DPP-4 inhibitors

Journal of Molecular Structure 1358 (2026)

Vipin Kumar; Manisha Nidhar; Nitish Kumar Yadav; Muhammad Sheraj; Sooraj Sura; Ashish Kumar Tewari

11

GPU-Accelerated Virtual Screening and Molecular Dynamics Simulations for Identification of Novel DPP-4 Inhibitors

ACS Omega 11(4) (2026)

Nathaly Vasquez-Martínez; Jonathan Trapala; Laura I. Álvarez‐Añorve; Rodolfo A. Lizárraga-Valadez; Martín González‐Andrade; Alejandro Sosa‐Peinado

12

Spiropyrrolizine derivatives as multitarget antidiabetic agents in obese type 2 diabetes: integrated in silico , in vitro , and in vivo evaluation of DPP-4 inhibition and hepatic enzyme modulation

Future Medicinal Chemistry 18(7) (2026)

Faiza I. A. Abdella; Dalal Alardan; Ismail Daoud; Nawal S. Alshammari; Ahlam Abdulrahman Alrashdi; Sarra Boudriga

13

Pyridazine- and triazine–acetophenone derivatives: synthesis, crystal structure, Hirshfeld surface, DFT analysis, and multitarget docking against DPP-4/CYP7A1/GSK-3β

Journal of Molecular Structure 1368 (2026)

Rana Rudh Pratap Singh; Vipin Kumar; Manisha Nidhar; Nitish Kumar Yadav; Niharika Upadhyay; A. Rekha; Gaurav Gupta; Deepika Raina; Ashish Kumar Tewari

14

Novel triazole-based piperidine DPP-4 inhibitors with potent anti-diabetic activity: design, synthesis, and biological evaluation

Results in Chemistry 27 (2026)

Yasaman Pourbaba; Pegah Pourshaban; Ali Hashemi; Amir Garmabdari; Zahra Sheikholislam; Leila Bayat; Nima Naderi; Mohammad Mahboubi‐Rabbani; Elham Rezaee; Sayyed Abbas Tabatabai

15

Targeting Gut Microbiota by DPP-4 Inhibitors in Obesity: Mechanistic Insights and Therapeutic Implications

Current Nutrition Reports 15(1) (2026)

Mansour Alanazi; Hayder M. Al‐kuraishy; Ahmed A. Mohamed; Shimaa Ali Abass; Mustafa M Shokr; Mubarak Alruwaili; Gaber El‐Saber Batiha

16

Effect of Kaempferia galanga L. on Xanthine Oxidase Activity and Arterial Stiffness in Hyperuricemia

Tropical Journal of Natural Product Research 9(2) (2025)

Patonah Hasimun; Yoga A. R. Muzaki; Jajang Japar Sodik; Ika K. Sukmawati; Herni Kusriani

17

Abordagem sobre Sistemas de Amortização à luz da Educação Financeira

Educação em Foco 25(46) (2022)

Bruno Gomes de Freitas; Valéria Guimarães Moreira

19

Dipeptidyl peptidase-4 inhibitors in combination therapy of type 2 diabetes mellitus: Optimal strategies and place in management algorithms

FOCUS Endocrinology 6(4) (2025)

Ушанова Фатима Омариевна; Tatiana Yu. Demidova; A. N. Levitskaya

20

Sarcopenia and Muscle Metabolism in Cardiovascular–Kidney–Metabolic Syndrome: Pathophysiology, Clinical Implications, and Therapeutic Strategies

Springer eBooks (2025)

Adina Carmen Ilie; Anca Iuliana Pîslaru; Sabinne-Marie Albişteanu; Ioana Dana Alexa

23

Structure-Based in Silico Insights of Sitagliptin Analogs against Dipeptidyl Peptidase-4

Biomedical & Pharmacology Journal 2(19) (2026)

Halah Abdul Sahib

24
25

Thiazole heterocycles: a promising scaffold for drug discovery in antidiabetic agent development

Journal of Molecular Structure 1382 (2026)

Gagandeep Kaur; Isha Rani; Vikas Sharma; Parul Sood

26

GLP-1 as a Regulator of Oxidative Signalling in Metabolic Health and Disease

Antioxidants 15(10) (2026)

Natalia Kurhaluk; Renata Kołodziejska; Галина Михайлівна Ткаченко

27

The first examples of monoethyl thioterephthalate containing multiply bonded Re2 complexes with potential antidiabetic activity: A combined experimental and in-silico study

Journal of Molecular Structure 1381 (2026)

Binjazar Ul Haq Islam; Sayoni Dam; Shilpi Chowdhury; Asmita Samadder; Suman Mallick

28

Putative predictive power of baseline cerebrospinal fluid dipeptidyl peptidase-4 on the conversion to secondary progressive multiple sclerosis

Neurological Research (2026)

Nuray Sancar; Şükrü Özaydın; Ahmed Serkan Emekli; Vuslat Yılmaz; Recai Türkoğlu; Erdem Tüzün